IDEXX Laboratories Inc (IDXX) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.

Total Revenue Chart for IDEXX Laboratories Inc

IDEXX Laboratories Inc (IDXX) revenue for FY2025 was USD 4.3B, a 10.4% change from FY2024. IDEXX Laboratories Inc's revenue grew from USD 30.5M in 1991 to USD 4.3B in 2025 (14010.5% over 34 years). Earnings per share grew from USD 0.25 in 2000 to USD 8.03 in 2022 (3062.5%). Revenue compound annual growth rate: 5-year CAGR of 9.7%, 10-year CAGR of 10.4%, 20-year CAGR of 10.0%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$46.54B
Implied Share Price
$590.00
Enterprise Value
$47.30B
Revenue (TTM)
$4.55B
EBITDA
$1.62B
Profit Margin
25.03%
Trailing P/E
41.14
Forward P/E
39.84
Price/Book (MRQ)
29.81
Price/Sales (TTM)
10.21
EV/EBITDA
30.37
EV/Revenue
10.64
Dividend Yield
—
Book Value
$19.64
Free Cash Flow (FY2025)
$1.05B
Free Cash Flow Yield
2.26%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.